EA200300770A1 - ANTAGONISTS OF EXCESSING AMINO ACID RECEPTORS - Google Patents
ANTAGONISTS OF EXCESSING AMINO ACID RECEPTORSInfo
- Publication number
- EA200300770A1 EA200300770A1 EA200300770A EA200300770A EA200300770A1 EA 200300770 A1 EA200300770 A1 EA 200300770A1 EA 200300770 A EA200300770 A EA 200300770A EA 200300770 A EA200300770 A EA 200300770A EA 200300770 A1 EA200300770 A1 EA 200300770A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- formula
- excessing
- antagonists
- amino acid
- acid receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Настоящее изобретение касается новых фармацевтически приемлемых солей соединений формулы I и формулы Ia, а также способов применения фармацевтически приемлемых солей и, кроме того, способов получения соединений формулы I и формулы Ia или их фармацевтически приемлемых солей. Соединения формулы I и формулы Ia могут использоваться для лечения неврологических нарушений, в частности мигрени.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to new pharmaceutically acceptable salts of compounds of formula I and formula Ia, as well as methods of using pharmaceutically acceptable salts and, in addition, methods for preparing compounds of formula I and formula Ia or their pharmaceutically acceptable salts. The compounds of formula I and formula Ia can be used to treat neurological disorders, in particular migraines. The international application was published together with an international search report.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26001401P | 2001-01-05 | 2001-01-05 | |
PCT/US2001/044715 WO2002053561A1 (en) | 2001-01-05 | 2001-12-20 | Excitatory amino acid receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200300770A1 true EA200300770A1 (en) | 2003-10-30 |
Family
ID=22987455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200300770A EA200300770A1 (en) | 2001-01-05 | 2001-12-20 | ANTAGONISTS OF EXCESSING AMINO ACID RECEPTORS |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1351955A1 (en) |
JP (1) | JP2004520335A (en) |
KR (1) | KR20030066797A (en) |
CN (1) | CN1484642A (en) |
AR (1) | AR035679A1 (en) |
BR (1) | BR0116672A (en) |
CA (1) | CA2431545A1 (en) |
CZ (1) | CZ20031856A3 (en) |
DZ (1) | DZ3460A1 (en) |
EA (1) | EA200300770A1 (en) |
EC (1) | ECSP034682A (en) |
HR (1) | HRP20030544A2 (en) |
HU (1) | HUP0302528A2 (en) |
IL (1) | IL156138A0 (en) |
MX (1) | MXPA03005981A (en) |
NO (1) | NO20032973L (en) |
NZ (1) | NZ525821A (en) |
PE (1) | PE20020792A1 (en) |
PL (1) | PL361934A1 (en) |
SK (1) | SK8242003A3 (en) |
TW (1) | TW591023B (en) |
WO (1) | WO2002053561A1 (en) |
ZA (1) | ZA200304311B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
SK11812000A3 (en) * | 1998-02-06 | 2001-08-06 | Smithkline Beecham Plc | Salts of paroxetine |
GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
TR200200066T2 (en) * | 1999-07-06 | 2002-04-22 | Eli Lilly And Company | Selective iGluR5 receptor antagonists for the treatment of migraine |
-
2001
- 2001-12-20 IL IL15613801A patent/IL156138A0/en unknown
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/en not_active IP Right Cessation
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/en unknown
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/en active Pending
- 2001-12-20 EA EA200300770A patent/EA200300770A1/en unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/en active Pending
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Application Discontinuation
- 2001-12-20 PL PL01361934A patent/PL361934A1/en not_active Application Discontinuation
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/en active
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/en not_active Application Discontinuation
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/en unknown
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/en unknown
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/en unknown
-
2002
- 2002-01-04 AR ARP020100030A patent/AR035679A1/en not_active Application Discontinuation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/en not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/en not_active IP Right Cessation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973L/en not_active Application Discontinuation
- 2003-07-03 HR HR20030544A patent/HRP20030544A2/en not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL156138A0 (en) | 2003-12-23 |
ZA200304311B (en) | 2004-09-02 |
NO20032973D0 (en) | 2003-06-27 |
EP1351955A1 (en) | 2003-10-15 |
NO20032973L (en) | 2003-06-27 |
CA2431545A1 (en) | 2002-07-11 |
HUP0302528A2 (en) | 2003-11-28 |
BR0116672A (en) | 2003-09-23 |
CZ20031856A3 (en) | 2003-09-17 |
PL361934A1 (en) | 2004-10-18 |
KR20030066797A (en) | 2003-08-09 |
SK8242003A3 (en) | 2004-01-08 |
CN1484642A (en) | 2004-03-24 |
WO2002053561A1 (en) | 2002-07-11 |
JP2004520335A (en) | 2004-07-08 |
ECSP034682A (en) | 2003-08-29 |
DZ3460A1 (en) | 2002-07-11 |
MXPA03005981A (en) | 2003-09-10 |
HRP20030544A2 (en) | 2004-08-31 |
AR035679A1 (en) | 2004-06-23 |
NZ525821A (en) | 2004-07-30 |
TW591023B (en) | 2004-06-11 |
PE20020792A1 (en) | 2002-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200300919A1 (en) | N-SUBSTITUTED NON-ARYL HETEROCYCLIC ANTAGONISTS NMDA / NR2B | |
EA200300171A1 (en) | CYCLOPENTANOINDOLS, COMPOSITIONS CONTAINING THE COMPONENTS, AND METHODS OF TREATMENT | |
EA200100971A1 (en) | NEW COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | |
EA200400595A1 (en) | BENZIMIDAZOLY, USED AS PROTEKINKINASE INHIBITORS | |
EA200401309A1 (en) | TRYZE-SUBSTITUTED HETEROARILES AND METHODS OF THEIR RECEPTION AND APPLICATION | |
EA200200546A1 (en) | SUSTAINABLE POLYMORPH OF N- (3-ETHINYLPHENYL) -6,7-BIS HYDROCHLORIDE (2-METHOXYETHOXY) -4-HINAZOLYNAMINE, METHODS FOR ITS PREPARATION AND PHARMACEUTICAL APPLICATIONS | |
EA200400953A1 (en) | SUBSTITUTED PYRIDINOES AS MAP-KINASE P38 MODULATORS | |
EA200500169A1 (en) | SUBSTITUTED DERIVATIVES 1,3-DIPHENYLPROP-2-EN-1-SHE, RECEIVING AND APPLICATION | |
EA200100748A1 (en) | MONOAMINE RETURN INHIBITORS FOR THE TREATMENT OF CNS DISORDERS | |
EA200500342A1 (en) | HETEROCYCLIC SUBSTITUTED PIPERASINES FOR THE TREATMENT OF SCHIZOPHRENIA | |
EA200300528A1 (en) | 1-ARYL-OR 1-ALKYLSULPHONYLETHETROCYCLYLBENZAZOLES AS LIGANDS 5-HYDROXITRIPTAMINE-6 | |
EA200500814A1 (en) | DERIVATIVES OF PYRROPOLYMIDININE | |
EA200400073A1 (en) | Pyrrolipyrimins as inhibitors of protein kinases | |
EA200300211A1 (en) | AZABICCAL COMPOUNDS, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS A MEDICINE, IN PARTICULAR AS ANTIBACTERIAL MEANS | |
EA200400892A1 (en) | DERIVATIVES NICOTINAMIDA USEFUL AS PDE4 INHIBITORS | |
EA200100203A1 (en) | DERIVATIVES 4,4-BIARILPIPERIDIN WITH ACTIVITY WITH RESPECT TO OPIOID RECEPTORS | |
EA200301306A1 (en) | DERIVATIVES 1-PHENYLSULFONIL-1,3-DIHYDRO-2H-INDOL-2-SHE, THEIR PRODUCTION AND THEIR THERAPEUTIC APPLICATION | |
EA200800760A1 (en) | PYRIDOPYRIMIDINONE INHIBITORS PI3Kα | |
EA200501274A1 (en) | PYRAZOLES AND METHODS FOR THEIR PRODUCTION AND APPLICATION | |
EA200201179A1 (en) | DERIVATIVES 2-AMINOKARBONIL-9H-PURINA | |
EA200300829A1 (en) | Derivatives of 1-aryl-or 1-alkylsulfonylbenzene as a ligand 5-hydroxytriptamine-6 | |
EA200300527A1 (en) | NEW TREATMENT METHODS FOR TIRED FOOT SYNDROME | |
EA200300619A1 (en) | SEROTONINERGIC MEANS | |
EA200300424A1 (en) | SALTS OF ISOTHIAZOLE-4-CARBOXAMIDE AND THEIR APPLICATION AS ANTIHYPERPROLIFERATIVE AGENTS | |
EA200970192A1 (en) | DERIVATIVES 5,6-BISARIL-2-PYRIDIN-CARBOXAMIDE, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY AS ANTAGONISTS OF UROTENZIN II RECEPTORS |